Standout Papers

Afatinib versus placebo for patients with advanced, metastatic non-small-c... 2008 2026 2014 2020 760
  1. Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial (2012)
    Vincent A. Miller, Vera Hirsh et al. The Lancet Oncology
  2. Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures (2008)
    Marie‐Caroline Dieu‐Nosjean, Martine Antoine et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 8 from Science/Nature 104 standout
Sub-graph 1 of 15

Citing Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Tertiary lymphoid structures in anticancer immunity
2024 Standout
107 intermediate papers

Works of Jacques Cadranel being referenced

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures
2008 Standout
Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.
2003
and 4 more

Author Peers

Author Last Decade Papers Cites
Jacques Cadranel 4003 3484 1215 1232 231 7.3k
Marie Wislez 3996 4379 949 1245 277 7.9k
Frederic B. Askin 4253 1645 1237 458 187 8.8k
P. Sève 1866 1186 586 1027 277 6.6k
Norma K.C. Ramsay 1036 2485 1407 2149 161 11.3k
Janick Sèlves 1496 2867 1426 999 132 8.3k
Bruce A. Woda 1746 2249 816 2100 182 8.9k
Marco Chilosi 4780 3389 1004 2785 284 12.6k
Ingo G.H. Schmidt‐Wolf 2813 3785 751 2880 245 10.2k
Saroj Vadhan‐Raj 1167 3505 401 1153 169 7.6k
Carlos E. Bacchi 1372 2104 940 407 229 5.6k

All Works

Loading papers...

Rankless by CCL
2026